Skip to main content
OpenTrials
Completed

NCT Number: NCT03300596

Brief New Treatment for Suicide Attempts

Individuals with alcohol or drug use problems who are hospitalized for suicide attempt are at high risk for reattempt. This treatment development study adapts a promising outpatient intervention to prevent suicide reattempt in order to administer it during hospitalization to individuals with alcohol and drug use problems, and to test the adapted intervention in a pilot randomized controlled trial.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Rochester Medical Center

Rochester, New York, 14642, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • suicide attempt within one week of hospitalization with acknowledgment of some intent to die using a standard item
  • problematic alcohol or drug use as determined by score >8 on Alcohol Use Disorders Identification Test, AUDIT or >3 on the 10-item version of the Drug Abuse Screening Test, DAST-10
  • admission to hospital
  • residence within 40 miles of Strong Memorial Hospital

Exclusion criteria

  • under age 18
  • treated in ED, CPEP, or observation unit only
  • unable to communicate with the researcher in English
  • unable to comprehend the nature of the study
  • participation untenable from a medical (e.g., intubated), psychiatric (e.g., florid psychosis), or behavioral (e.g., refusing to speak with staff) standpoint
  • short hospital length of stay, ruling out administering three sessions of the therapy prior to discharge

Treatment and study plan

Brief intervention to prevent suicide attempt

Behavioral

A patient-centered, 3-session intervention that calls for videotaping the narrative story of a patient's suicide attempt, in his/her own words (session 1); reviewing segments of the tape to arrive at a shared understanding of the attempt and the sequence of events that led to it (session 2); and using this information, along with a homework task completed by the patient in-between sessions, in order to develop a collaborative, comprehensive written safety plan that addresses the patient's unique vulnerabilities (session 3).

Other names: Modification of the Attempted Suicide Short Intervention Program (ASSIP)

Enhanced Treatment as Usual

Behavioral

Safety procedures' control intervention. For these procedures we will share summary results of the research assessments regarding suicidal thoughts, suicidal behaviors, alcohol and drug use and related problems, and depressive symptoms with appropriate hospital clinical staff. We will also arrange to send this information, with participants' permission, to their ongoing therapist or treatment program and, if none exists, to the therapist or program to which they are being referred. In this regard, the research assessment protocol serves a dual function of helping with additional monitoring of high-risk patients in addition to providing data for the study.

Primary outcomes

  1. suicide reattempt

    Time frame: 6 months

    number who reattempt suicide

Sponsors and collaborators

Lead sponsor

University of Rochester

Other

Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Registry information

Official study title

Suicidal Adults With Alcohol or Drug Use Problems: A New Hospital-based Treatment

Important dates

Study start
2018
Primary completion
2020
Study completion
2020
First posted
Oct 3, 2017
Registry last updated
Sep 17, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.